ROCKVILLE, Md., May 28 Novavax, Inc.(Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr.Rahul Singhvi, President and Chief Executive Officer, will be presenting atthe FBR Capital Markets 12th Annual Spring Investor Conference at 9:45 am. onMay 29, 2008 at The Grand Hyatt Hotel in New York. Dr. Singhvi will provide anoverview of the company's strategy, research and development progress. A linkto the live presentation can be accessed via the Company website atwww.novavax.com. An archive of the presentation will be available one hourafter the event on the Novavax website for 90 days.
Novavax, Inc. is a clinical stage biotechnology company, creating novelvaccines to address a broad range of infectious diseases worldwide usingadvanced proprietary viruslike particle (VLP) technology. The Company producesthese VLP based, potent, recombinant vaccines utilizing a new, efficientmanufacturing solution. Additional information about Novavax is available atwww.novavax.com and in the Company's various filings with the Securities andExchange Commission.
SOURCE Novavax, Inc.